Clinical trial
Effects of the Dose of Erythropoiesis Stimulating Agents on Cardiac-cerebrovascular Outcomes Quality of Life and Costs in Hemodialysis Patients. The Clinical Evaluation of the DOSe of Erythropoietins (C.E. DOSE) Trial
NCT00827021 is registered in ClinicalTrials.gov with Giovanni FM Strippoli, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of the Dose of Erythropoiesis Stimulating Agents on Cardiac-cerebrovascular Outcomes Quality of Life and Costs in Hemodialysis Patients. The Clinical Evaluation of the DOSe of Erythropoietins (C.E. DOSE) Trial
- Lead sponsor
- Giovanni FM Strippoli, MD
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- July 31, 2014
- Enrollment
- 656 (actual)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.